Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-26T05:41:27.094Z Has data issue: false hasContentIssue false
  • English
  • Français

In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine

Published online by Cambridge University Press:  01 June 1997

M. HASSAN ALIN
M. HASSAN ALIN
Affiliation:
Division of Biopharmaceutics and Pharmacokinetics, Department of Pharmacy, Box 580, Biomedical Centre, Uppsala University, 75123 Uppsala, Sweden
Get access Rights & Permissions [Opens in a new window]

Abstract

A 30-h in vitro susceptibility test of Plasmodium falciparum wild isolates to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine was performed in Kibaha, Tanzania. A sigmoid Emax model was fitted to all data for each isolate and drug combination. Artemisinin and mefloquine exhibited 100% growth inhibition against all isolates tested (n=69–74). The EC50 values for artemisinin and mefloquine were 44 and 146 nM respectively. Chloroquine and sulfadoxine/pyrimethamine resistance was 30% and 13% respectively. Susceptibility parameters (EC50, 90, 95 and 99 values and s) varied between compounds and isolates indicating the different sensitivity of P. falciparum isolates. No correlation between susceptibility parameters of artemisinin and the other compounds was found. The high in vitro activities of artemisinin and mefloquine indicate their potential role for the treatment of multidrug-resistant malaria in Africa.

Keywords

Plasmodium falciparumsusceptibilityartemisininTanzania
Type
Research Article
Information
Parasitology , Volume 114 , Issue 6 , June 1997 , pp. 503 - 506
Copyright
1997 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)